CoreCap Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
CoreCap Advisors's RGEN Position: Q3 2026 in Review
CoreCap Advisors increased its Repligen (RGEN) stake by 1,275% in Q3 2026, buying an estimated $41.5K and bringing the position to 275 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1368.
CoreCap Advisors first reported a position in RGEN in Q4 2021 and has held it in 6 quarters since. 85 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.
- CoreCap Advisors held 275 shares of Repligen worth $52.9K as of Q3 2026.
- CoreCap Advisors bought 255 Repligen shares in Q3 2026, an estimated $41.5K.
- Repligen made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1368 holding.
- CoreCap Advisors first reported a position in Repligen in Q4 2021 and has held it in 6 quarters since.
- 85 funds tracked by Wall St. Rank held Repligen as of Q3 2026.
Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.